Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Current and historical concept of neuromyelitis optica].
Proximal nerve lesions in early Guillain-Barré syndrome: implications for pathogenesis and disease classification.
[Sarcoid neuropathy].
Is there a (host) genetic predisposition to progressive multifocal leukoencephalopathy?
The natural dual cyclooxygenase and 5-lipoxygenase inhibitor flavocoxid is protective in EAE through effects on Th1/Th17 differentiation and macrophage/microglia activation.
Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome.
Presence of the HLADR13 allele among Mexican Mestizos suggests a protective factor against relapsing-remitting multiple sclerosis (RRMS).
Are Polyphenols Strong Dietary Agents Against Neurotoxicity and Neurodegeneration?
Favorable outcome of granulocyte colony-stimulating factor use in neuromyelitis optica patients presenting with agranulocytosis in the setting of rituximab.
Exercising Impacts on Fatigue, Depression, and Paresthesia in Female Patients with MS.
Multiple sclerosis and related disorders: evolving pathophysiologic insights.
A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
Fatigue and heat sensitivity in patients with multiple sclerosis.
Impact of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod: Subgroup analyses of the Fingolimod Research Evaluating Effects of Daily Oral Therapy in Multiple Sclerosis (FREEDOMS) study.
Successful antiviral treatment of chronic hepatitis C in patients with rare comorbidities. Two case-reports.
Decreased serum IL-27 and IL-35 levels are associated with disease severity in neuromyelitis optica spectrum disorders.
Response to Comment on "Thiamine Deficiency Promotes T Cell Infiltration in Experimental Autoimmune Encephalomyelitis: The Involvement of CCL2".
Structural correlates for fatigue in early relapsing remitting multiple sclerosis.
Immunization of mice with a peptide derived from the HTLV-1 TAX1BP1 protein induces cross-reactive antibodies against aquaporin 4.
Effects of Tysabri over 12 months on multiple sclerosis (MS) related fatigue in patients with relapsing remitting multiple sclerosis (RRMS) (TYNERGY)
New pharmacological approaches against chronic bowel and bladder problems in paralytics.
Absence of MxA induction is related to a poor clinical response to interferon beta treatment in multiple sclerosis patients.
Autopsy-proven demyelination associated with infliximab treatment.
Control of microglial neurotoxicity by the fractalkine receptor.
Anti-annexin antibodies, cholesterol levels and disability in multiple sclerosis.

Pages